Pfizer's Paxlovid only helped seniors avoid hospitalization and death, new NEJM study finds
Usage of Pfizer’s Covid-19 treatment Paxlovid has spiked across the US in recent months, with more than 2 million courses administered during this latest Omicron …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.